$CCEP

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

Original reporting
Published Sep 14, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transactions in Own Shares — source image
Decision brief

The 30-second read

$CCEPBullishHigh
01

Why it matters

The buyback reflects strong cash flow and may improve earnings per share, offering a short‑term catalyst for the stock.

02

Market read

A fresh buyback tranche provides a concrete, actionable signal for traders, likely supporting CCEP's price in the near term.

03

What to watch

The tranche size relative to the total programme and the timing amid broader market volatility could temper the expected price support.

Relevance 7/10Novelty 7/10Timing: today

Background

Coca‑Cola Europacific Partners (CCEP) announced a multi‑venue share repurchase covering both US and London exchanges, cancelling the shares to reduce outstanding equity.

Company-level read

Ticker impact

$CCEPBullishHigh confidence
Context

Coca‑Cola Europacific Partners disclosed a fresh share buyback tranche of 285,000 US‑listed and 118,748 London‑listed ordinary shares purchased between 7‑11 Sept 2026, to be cancelled under its EUR 1 bn buyback programme.

Expected impact

Modest upside pressure over the next few trading days, especially if the buyback size exceeds market expectations.

Evidence & confidence

Buybacks are a direct capital return; the disclosed tranche is sizable relative to daily volume and follows a previously announced programme, indicating execution of management’s capital allocation plan.

Market effects

The consumer staples sector may see a slight uplift as a major peer demonstrates strong cash generation and willingness to return capital.

European markets could experience modest buying pressure on listed consumer‑goods stocks, while US pre‑market activity may see a small boost for CCEP ADR.

Limited to CCEP and its sector; no broad macro impact.

Counterpoint

If the buyback is perceived as a lack of growth opportunities, investors might view it as a defensive move and could short the stock.

Key entities

  • Coca‑Cola Europacific Partners

    Consumer‑goods company listed on NASDAQ, LSE, and Euronext Amsterdam.

  • Goldman Sachs & Co. LLC / Goldman Sachs International

    Seller of the repurchased shares.

Related articles

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.